Medical comms - Articles

In an ever-evolving field like medical writing, versatility is not just a skill – it’s a necessity. As the demands of the healthcare sector grow increasingly complex, you should be looking for new ways to diversify your portfolio and effectively demonstrate your range of skills and depth of knowledge.
In an ever-evolving field like medical writing, versatility is not just a skill – it’s a necessity. As the demands of the healthcare sector grow increasingly complex, you should be looking for new ways to diversify your portfolio and effectively demonstrate your range of skills and depth of knowledge. A well-crafted, diverse portfolio will showcase your competence across various sub-disciplines, demonstrating your versatility and positioning you for success in the competitive 2024 job market. …

Mtech Access are now part of Petauri. This marks a significant and exciting milestone in our journey, and aligns with our commitment to partnering with industry to bring life-enhancing technologies to market, providing more patient choice and meeting the needs of the healthcare environment.
What this means for our clients: Enhanced services: This strategic move will allow us to offer greater breadth and depth of technical and consulting experience, as well as market coverage for our clients. Continuity and stability: The quality of work and client service that you have come to expect, along with your current projects and relationships, will remain unchanged. Innovative solutions: Leveraging the strengths of the Petauri group, we will build on our commitment to growth and inn…

Transitioning from a Medical Doctor's traditional path to the world of a Freelance MedComms Consultant has been exciting and seasoned with opportunities. This shift has allowed me to leverage my extensive international medical training, teaching, and biomedical research experience and introduced me to a world where flexibility, continuous learning, and building long-standing client relationships are paramount.
Transitioning from a Medical Doctor's traditional path to the world of a Freelance MedComms Consultant has been exciting and seasoned with opportunities. This shift has allowed me to leverage my extensive international medical training, teaching, and biomedical research experience and introduced me to a world where flexibility, continuous learning, and building long-standing client re…

Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight important considerations for companies seeking to infiltrate this key market.
Health economic modelling is fundamental to market access, in both health technology assessment (HTA) and pre and post-launch engagement. It is of value globally, but holds particular importance in markets across Europe, the UK, and Canada, among others. Its application in the US, however, is less established. With a dedicated Health Economics Team, economic modelling is a key area in which Mtech Access support clients. Whilst there are variations in the approaches between HTA markets, we can see commonalities in the requirement for e…

From nurturing a positive work culture to empowering and developing your people for success, Pioneer Group sets out some top tips for building a high-performance team as a life science company.
When it comes to recruitment, the life sciences industry is undoubtedly highly competitive. With demand for skilled professionals often outpacing the supply, attracting (and retaining) qualified candidates with the right expertise can be a significant challenge for many life science companies. From nurturing a positive work culture to empowering and developing your people for success, Pioneer Group sets out some top tips for building a high-performance team as a life science company. Invest in Graduate Programmes Investing in graduate outreach can help to bridge the skills gap in life sciences, and…

• Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price • Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close • Upon closing, Baird Medical is expected to trade on Nasdaq under the ticker symbol “BDMD
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close Upon closing, Baird Medical is expect…

Specialists from across Mtech Access look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as our experts give their hot take on each trend, sharing their perspectives on the topics in these areas (get ready – it’s a jam-packed read!).
    Executive Summary Hayley Shoel and Abigail Beveridge, from our Medical Writing Team, outline what to expect from this paper in the below Executive Summary. In January 2024, ISPOR published their ‘2024–2025 Top HEOR Trends’ report, a horizon scanning publication that highlighted key trends affecting healthcare decision-making around the world. Since these trends resonate with our own research and activities here at Mtech Access, experts within our team have come together to share their perspectives on each of the t…

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways to cut corners on systematic reviews. Sometimes there are true efficiencies to be made. Yet, all compromises have consequences. In this article, we delve into 11 common problems that may arise when cost-cutting compromises the quality of your systematic literature review.
1. Choosing the wrong type of systematic review methodology Selecting the wrong type of methodology for your review can have profound implications. A robust, gold standard Cochrane methodology involves two reviewers at all stages of the review, to avoid bias in the identification and presentation of the evidence, and ensur…

CD73, also known as ecto-5′-nucleotidase, is a groundbreaking immunoinhibitory protein that assumes a pivotal role in tumor growth and metastasis. Its primary function revolves around converting extracellular ATP into immunosuppressive adenosine, working in tandem with CD39 within normal tissues to curtail excessive immune reactions. However, this mechanism is often hijacked by tumors, utilizing CD73 to foster an adenosinergic process that shields them from immune assaults.
Exploring the Structure and Function of CD73 The CD73 gene finds its home in the 6q14.3 region of human chromosome 6, encoding a protein comprised of 549 amino acid residues. CD73 functions as a glycosylphospholipase, residing on the cell membrane surface and engaging with the extracellular matrix through its extracellul…

GPC3, with its full name Glypican-3, is a member of the heparan sulfate proteoglycan family and is connected to the cell surface through the glycosylphosphatidylinositol anchor on the cell membrane. The GPC3 gene was first detected in a rat epithelial cell line in 1988. In the human body, the GPC3 protein expressed by the GPC3 gene is significantly different in different developmental stages and different tissues, such as low expression or no expression in gastric cancer, breast cancer, ovarian cancer and other cancers, but often in hepatocellular carcinoma is overexpressed.
The Structure of GPC3 GPC3, or Glypican-3, is an oncofetal glycoprotein tethered to the cell membrane via a glycophosphatidylinositol (GPI) anchor[1-2]. Its core protein comprises 580 amino acids and weighs in at 70 k…

Specialised commissioning continues to be an issue of significance and uncertainty for both the NHS and industry. What do the latest reports of regional push back on the plans for devolution to Integrated Care Boards (ICBs) mean? Learn more about our upcoming webinar here.
For the past 2 years, Pharma, Medtech, and Diagnostic companies have identified the delegation of specialised commissioning to the new Integrated Care Boards (ICBs) as a key risk to their UK market access strategies. With its importance to income and the high risk of change devolution seems to promise, specialised commissioning is an obvious issue for providers of these products to place at the top of their risk logs. The devolution plans are also a risk for the NHS. Not least, because around two-thirds of the income of a…

Interleukin-6 (IL-6) is the principal member of the cytokine IL-6 superfamily[1-2]. This protein is comprised of 212 amino acids and has a mass of 21–26 kDa. As a cytokine, IL-6 participates in the innate immune response[3]. IL-6 potently induces acute-phase proteins, C-reactive protein (CRP), several complement system proteins, and the coagulation cascade[4]. IL-6 also regulates body thermogenesis by acting as an endogenous pyrogen; stimulates hematopoietic precursor growth; and promotes T and B lymphocyte differentiation and maturation[5-6].
Function Introduction of IL-6 Interleukin-6 (IL-6), a versatile cytokine, plays a pivotal role in immune regulation, inflammatory responses, as well as cell proliferation and differentiation. Produced by a range of cell types including T cells, B ce…

- Understanding the definition and role of CD19 in the immune system. - Introduction to the structure, composition, and signal pathway of CD19. - Knowledge about CD19 related diseases and research purpose products
What is CD19 Understanding CD19: Definition and Role in the Immune System CD19, also known as Cluster of Differentiation 19, is a cell surface protein belonging to the immunoglobulin superfamily. It serves as a crucial marker for B cells, playing a pivotal role in the human immune system. While predominantly found on the surface of B cells, CD19 is rarely expressed on other immune cells. Its significance lies in its involvement in B cell development and activation, making it a valuable target for research and clinical applications. The Structural Composition of CD19 The human CD…

DLL3 (DELTA-LIKE Protein 3) is encoded by the human gene and belongs to the Delta-Like protein family. It is a transmembrane protein involved in cell signaling, cell fate determination, and cell differentiation. The Delta-Like protein family comprises ligands that interact with NOTCH receptors, crucial for cell development and differentiation. DLL3 plays a pivotal role in neurogenesis, contributing to the generation of neurons during embryonic development. DLL3 has garnered significant interest in cancer research, particularly in certain types of cancer. Elevated DLL3 expression has been detected in some small cell lung cancer (SCLC) and other neuroendocrine tumors. As a result, targeted treatment approaches have been developed to inhibit DLL3, providing a potential treatment strategy for these aggressive cancers.

B-lymphocyte antigen CD20 (called CD20) is known as an activated-glycosylated phosphoprotein which is expressed on the surface of all B-cells. CD20 is involved in the regulation of trans-membrane Ca2+ conductance and also play critical roles in cell‐cycle progression during human B cell proliferation and activation.
Structure of CD20 The CD20 protein presents a unique arrangement, featuring four membrane-spanning domains. Notably, both the amino and carboxy termini of the protein are positioned within the cytoplasm. An intriguing aspect of this structure is the existence of a short extracellular segment comprising approximately 43 residues, found between the third and fourth transmembrane regions[1]. This distinctive configuration, deeply embedded in the cell membrane, serves to prevent t…

Interleukin-1 family is a family of cytokine proteins, which includes IL-1α, IL-1β, IL-18 and a series of related molecules. Members of the IL-1 family play an important role in immune regulation and inflammatory responses. By binding to specific receptors, they trigger intracellular signaling, triggering inflammation, activation of immune cells, and modulation of biological effects
IL-1α and IL-1β: Key Players in Inflammation and Disease Pathogenesis IL-1α and IL-1β represent the prototypical and crucial members of the IL-1 family, which are synthesized by various cells, including monocytes, macrophages, dendritic cells, and others. These interleukins assume a significant regulatory function in the inflammatory response, stimulating immune cells to generate additional inflammatory mediat…

Programmed death protein 1 (PD1) is a common immunosuppressive member on the surface of T cells and plays an imperative part in downregulating the immune system and advancing self-tolerance. Its ligand programmed cell death ligand 1 (PDL1) is overexpressed on the surface of malignant tumor cells, where it binds to PD1, inhibits the proliferation of PD1-positive cells, and participates in the immune evasion of tumors leading to treatment failure. The PD1/PDL1-based pathway is of great value in immunotherapy of cancer and has become an important immune checkpoint in recent years.
The Structure and Function of PD-1 PD-1 is a type I membrane protein composed of 288 amino acids. As a member of the CD28/CTLA-4 family of T cell regulators, PD-1 plays a crucial role in modulating T cell responses…

How can you ensure that the market access materials, value proposition and evidence developed by global teams, will resonate for your local audience? In this article, our experts pool their knowledge to share their top tips for successfully taking global materials local.
How can you ensure that the market access materials, value proposition and evidence developed by global teams will resonate for your local audience? National market access teams and other local affiliates are regularly required to adapt global value materials to reflect the nuances and requirements of their local healthcare systems. At Mtech Access, we have a wealth of experience in developing customer communication materials at both global and affiliate level. Leading Pharma and Medtech companies regularly engage…

Dickkopf-1 (DKK1), is a protein that plays a critical role in regulating the Wnt signaling pathway, which is involved in various cellular processes, including cell proliferation, differentiation, and embryonic development. It is an important antagonist of the Wnt pathway, meaning that it inhibits Wnt signaling by binding to specific receptors and preventing the activation of downstream signaling molecules.
Introduction to DKK1 Dickkopf-1 (DKK1), is a protein that plays a critical role in regulating the Wnt signaling pathway, which is involved in various cellular processes, including cell proliferation, differentiation, and embryonic development. It is an important antagonist of the Wnt pathway, meaning that it inhibits Wnt signaling by binding to specific receptors and preventing the acti…

A tumor suppressor gene, also known as anti-onco gene, is an essential component of the body's defense against cancer. It usually facilitates apoptosis. With its absence, the human body will be functioning without its “brake” of cell proliferation. Cells are potent to go under abnormal growth processes and finally lead to tumor/cancer.
About Tumor Suppressor Genes A tumor suppressor gene, also known as anti-onco gene, is an essential component of the body's defense against cancer. It usually facilitates apoptosis. With its absence, the human body will be functioning without its “brake” of cell proliferation. Cells are potent to go under abnormal growth processes and finally lead to tumor/cancer. Here are some key features and functions of tumor suppressor genes: Inhibition of Cell Growth:…